Ovid Therapeutics Inc.

SEC 4 · Filed

0001256153-25-000004Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Dec 15, 2025

Conversion by LEVIN JEREMY M

Security
Series B Convertible Preferred Stock
Code
C
Shares
71
Price per share
0.00
Structured facts
{
  "code": "C",
  "date": "2025-12-15",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer\u0027s Stockholders on December 11, 2025."
  },
  "owners": [
    {
      "cik": "0001256153",
      "name": "LEVIN JEREMY M",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO"
    }
  ],
  "ownership": "D",
  "post_shares": "0",
  "price": "0",
  "row": 4,
  "rule_10b5_1": "0",
  "security": "Series B Convertible Preferred Stock",
  "shares": "71",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "71000"
}
Insider transactionsEvent date Dec 11, 2025

Purchase by LEVIN JEREMY M

Security
Series B Warrant (right to buy)
Code
P
Shares
35,500
Price per share
Unreported
Structured facts
{
  "code": "P",
  "date": "2025-12-11",
  "direction": "A",
  "exercise_price": "1.40",
  "expiration": "2030-10-06",
  "footnotes": {
    "F3": "The reported securities are included within 71 investment units purchased by the Reporting Person for $1,400 per investment unit. Each investment unit consists of one share of Series B Convertible Preferred Stock, one Series A Warrant to purchase 666.66 shares of common stock, and one Series B Warrant to purchase 500 shares of common stock.",
    "F6": "Each Series B Warrant became immediately exercisable pursuant to the approval of the Issuer\u0027s Stockholders on December 11, 2025."
  },
  "owners": [
    {
      "cik": "0001256153",
      "name": "LEVIN JEREMY M",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO"
    }
  ],
  "ownership": "D",
  "post_shares": "35500",
  "price": null,
  "row": 3,
  "rule_10b5_1": "0",
  "security": "Series B Warrant (right to buy)",
  "shares": "35500",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "35500"
}
Insider transactionsEvent date Dec 11, 2025

Purchase by LEVIN JEREMY M

Security
Series A Warrant (right to buy)
Code
P
Shares
47,333
Price per share
Unreported
Structured facts
{
  "code": "P",
  "date": "2025-12-11",
  "direction": "A",
  "exercise_price": "1.40",
  "expiration": null,
  "footnotes": {
    "F3": "The reported securities are included within 71 investment units purchased by the Reporting Person for $1,400 per investment unit. Each investment unit consists of one share of Series B Convertible Preferred Stock, one Series A Warrant to purchase 666.66 shares of common stock, and one Series B Warrant to purchase 500 shares of common stock.",
    "F4": "Each Series A Warrant became immediately exercisable pursuant to the approval of the Issuer\u0027s Stockholders on December 11, 2025.",
    "F5": "The Series A Warrants will terminate upon the earlier of (a) the 30th calendar day following date on which we publicly announce the clearance of the first of any investigational new drug application, clinical trial application or other foreign equivalent with respect to the clinical development of our OV4071 product candidate; provided that such 30-calendar day period shall not commence unless and until a registration statement covering the resale of the shares of Common Stock issuable upon exercise of the Series A Warrants is effective; and (b) October 6, 2030."
  },
  "owners": [
    {
      "cik": "0001256153",
      "name": "LEVIN JEREMY M",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO"
    }
  ],
  "ownership": "D",
  "post_shares": "47333",
  "price": null,
  "row": 2,
  "rule_10b5_1": "0",
  "security": "Series A Warrant (right to buy)",
  "shares": "47333",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "47333"
}
Insider transactionsEvent date Dec 11, 2025

Purchase by LEVIN JEREMY M

Security
Series B Convertible Preferred Stock
Code
P
Shares
71
Price per share
Unreported
Structured facts
{
  "code": "P",
  "date": "2025-12-11",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer\u0027s Stockholders on December 11, 2025.",
    "F3": "The reported securities are included within 71 investment units purchased by the Reporting Person for $1,400 per investment unit. Each investment unit consists of one share of Series B Convertible Preferred Stock, one Series A Warrant to purchase 666.66 shares of common stock, and one Series B Warrant to purchase 500 shares of common stock."
  },
  "owners": [
    {
      "cik": "0001256153",
      "name": "LEVIN JEREMY M",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO"
    }
  ],
  "ownership": "D",
  "post_shares": "71",
  "price": null,
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Series B Convertible Preferred Stock",
  "shares": "71",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "71000"
}
Insider transactionsEvent date Dec 15, 2025

Conversion by LEVIN JEREMY M

Security
Common Stock
Code
C
Shares
71,000
Price per share
Unreported
Structured facts
{
  "code": "C",
  "date": "2025-12-15",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer\u0027s Stockholders on December 11, 2025."
  },
  "owners": [
    {
      "cik": "0001256153",
      "name": "LEVIN JEREMY M",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO"
    }
  ],
  "ownership": "D",
  "post_shares": "3687715",
  "price": null,
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "71000",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}